Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 2
2005 1
2006 1
2007 1
2008 12
2009 11
2010 15
2011 14
2012 23
2013 22
2014 21
2015 16
2016 18
2017 28
2018 23
2019 25
2020 42
2021 33
2022 37
2023 37
2024 32

Text availability

Article attribute

Article type

Publication date

Search Results

372 results

Results by year

Filters applied: . Clear all
Page 1
The CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for Gastric Cancer Patients who Receive Curative Treatment.
Aoyama T, Maezawa Y, Hashimoto I, Hara K, Tamagawa A, Kazama K, Kato A, Cho H, Nakazono M, Numata M, Kawahara S, Tanabe M, Morita J, Oshima T, Saito A, Yukawa N, Rino Y. Aoyama T, et al. Among authors: oshima t. Anticancer Res. 2024 Apr;44(4):1629-1636. doi: 10.21873/anticanres.16961. Anticancer Res. 2024. PMID: 38537973
Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With Pancreatic Cancer Treated With Perioperative Adjuvant Chemotherapy.
Kawahara S, Aoyama T, Murakawa M, Kanemoto R, Takahashi D, Kamioka Y, Hashimoto I, Maezawa Y, Kobayashi S, Ueno M, Yamamoto N, Oshima T, Yukawa N, Rino Y, Saito A, Morinaga S. Kawahara S, et al. Among authors: oshima t. Anticancer Res. 2024 Apr;44(4):1711-1718. doi: 10.21873/anticanres.16970. Anticancer Res. 2024. PMID: 38537971
Protocol of a phase II study investigating the efficacy and safety of trifluridine/tipiracil plus ramucirumab as a third-line or later treatment for advanced gastric cancer.
Nakanishi K, Tanaka C, Kanda M, Miyata K, Machida N, Sakai M, Kobayashi D, Teramoto H, Ishiyama A, Sato B, Oshima T, Kajikawa M, Matsushita H, Ishigure K, Yamashita K, Fujitake S, Sueoka S, Asada T, Shimizu D, Sugita S, Kuwatsuka Y, Maeda O, Furune S, Murotani K, Ando Y, Ebata T, Kodera Y. Nakanishi K, et al. Among authors: oshima t. Nagoya J Med Sci. 2024 Feb;86(1):43-51. doi: 10.18999/nagjms.86.1.43. Nagoya J Med Sci. 2024. PMID: 38505718 Free PMC article.
Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative Treatment.
Fukuda M, Aoyama T, Hashimoto I, Maezawa Y, Kato A, Hara K, Kazama K, Komori K, Tamagawa A, Cho H, Ishiguro T, Segami K, Nakazono M, Otani K, Sawazaki S, Numata M, Kawahara S, Oshima T, Saito A, Yukawa N, Rino Y. Fukuda M, et al. Among authors: oshima t. In Vivo. 2024 Mar-Apr;38(2):904-910. doi: 10.21873/invivo.13517. In Vivo. 2024. PMID: 38418138 Free PMC article.
The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T, Kato A, Hashimoto I, Maezawa Y, Hara K, Kazama K, Komori K, Tamagawa H, Tamagawa A, Nagasawa S, Cho H, Segami K, Nakazono M, Otani K, Sawazaki S, Numata M, Kamiya N, Yoshizawa S, Kawahara S, Oshima T, Saito A, Yukawa N, Rino Y. Aoyama T, et al. Among authors: oshima t. In Vivo. 2024 Mar-Apr;38(2):890-896. doi: 10.21873/invivo.13515. In Vivo. 2024. PMID: 38418121 Free PMC article.
372 results